Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation

Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M. Zetola, Drew Weissman, Tawanda Gumbo, Gregory P. Bisson

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds